Company intelligence / Profile preview

Inncelerex

Ownership: Private
Development stage: Phase 1

Overview

Inncelerex is a specialized CRO and drug development consultancy with deep expertise in clinical pharmacology, pharmacometrics, modeling & simulation, pre-clinical safety/toxicology, and translational medicine. The team has contributed to the development and registration of numerous major medicines but does not have its own proprietary clinical pipeline. Instead, it provides expert services to biotech and pharma companies across all stages of drug development from candidate selection through early clinical trials.

Modalities: Small moleculeBiologicMonoclonal antibody
Industry: Contract Research Organization

Partnerships

Works with biotech/pharma clients globally.

Beyond the preview

Go deeper on Inncelerex.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Inncelerex.

Explore the full profile